| Abstract | Glaukom je vodeći uzrok ireverzibilne sljepoće na globalnoj razini. Pripada
skupini optičke neuropatije koja je karakterizirana progresivnom degeneracijom
ganglijskih stanica retine. Klasificira se u dvije osnovne skupine: glaukom
otvorenog kuta i glaukom zatvorenog kuta. Glaukom je često asimptomatski.
Nakon što se postavi dijagnoza glaukoma, bolesnicima je potrebno cjeloživotno
liječenje koje se sastoji od povremenih kontrolnih posjeta, pretraga, upotrebe
lijekova i kirurškog zahvata. Pokazalo se da navedeno izaziva anksioznost i
depresiju. Vrlo bitno je istražiti učestalost anksioznosti i depresije kod bolesnika
s glaukomom kako bi se identificirali bolesnici s najvećim rizikom od razvoja
istih te planirale strategije za njihovu prevenciju i liječenje. Zbog toga je
provedeno ovo istraživanje čiji je cilj bio ispitati psihološke aspekte glaukoma
kod bolesnika s glaukomom, ispitati jesu li bolesnici tjeskobni zbog dijagnoze
glaukoma, boje li se sljepoće, koliko ih dijagnoza ometa u obavljanju
svakodnevnih aktivnosti te utječe li glaukom na njihovu kvalitetu života. U
istraživanju su sudjelovali bolesnici s potvrđenom dijagnozom glaukoma i koji
dolaze na kontrolne preglede u ambulantu za glaukom. Istraživanje je
provedeno u KB Dubrava u Zagrebu na uzorku od 100 bolesnika, a trajalo je od
12.07.2023. do 31.08.2023. Provedeno je ispunjavanjem anketnog upitnika od
strane bolesnika koje je bilo dobrovoljno i anonimno. Podaci su obrađeni
deskriptivnom i inferencijalnom statistikom. Rezultati su pokazali kako je
kvaliteta života bolesnika s glaukomom dobra. Međutim, pokazalo se da postoji
značajna razlika u psihološkim aspektima glaukoma ovisno o obliku glaukoma,
te da dob, spol, zanimanje i stupanj obrazovanja također nemaju značajan
utjecaj na psihološki status bolesnika. Kako bi se bolesnicima pružila što
kvalitetnija skrb potrebno je provoditi istraživanja. Tu važnu ulogu imaju visoko
educirane sestre koje svojim znanjem, iskustvom i istraživačkim radom mogu
doći do novih saznanja koja će doprinijeti samoj kvaliteti i pristupu liječenja
bolesnika s glaukomom. |
| Abstract (english) | Glaucoma is the leading cause of irreversible blindness globally. It belongs
to the group of optic neuropathy, which is characterized by progressive
degeneration of retinal ganglion cells. It is classified into two basic groups: open
- angle glaucoma and angle - closure glaucoma. Glaucoma is often
asymptomatic. After the diagnosis of glaucoma is made, patients need lifelong
treatment, which consists of periodic control visits, tests, medication and
surgery. This has been shown to cause anxiety and depression. It is very
important to investigate the frequency of anxiety and depression in patients with
glaucoma in order to identify patients with the highest risk of developing them
and to plan strategies for their prevention and treatment. The aim of this
research was to examine the psychological aspects of glaucoma in patients with
glaucoma, to examine whether patients are anxious because of a glaucoma
diagnosis, whether they are afraid of blindness, how much the diagnosis
interferes with their daily activities, and how glaucoma affects their quality of life.
Patients with a confirmed diagnosis of glaucoma and who come for follow - up
examinations at the glaucoma clinic participated in the study. The research was
conducted in KB Dubrava in Zagreb on a sample of 100 patients, from 12 July
2023 – 31 August 2023. It was carried out by filling in a questionnaire by the
patient, which was voluntary and anonymous. The data were processed with
descriptive and inferential statistics. The results showed that the quality of life of
patients with glaucoma is good. However, it was shown that there is a
significant difference in the psychological aspects of glaucoma depending on
the form of glaucoma, and that age, gender, profession and level of education
also have no significant impact on the psychological status of the patient.This
important role is played by highly educated nurses who, with their knowledge,
experience and research work, can gain new knowledge that will contribute to
the very quality and approach to treatment of patients with glaucoma. |
